@article{oai:nagasaki-u.repo.nii.ac.jp:00020280,
 author = {Matsuo, Kengo and Murase, Kunihiko and Kanzaki, Shinichirou and Akiyama, Tetsuji and Nagasaki, Yoshikazu and Koga, Nobuhiko and Isomoto, Hajime and Takeshima, Fuminao and Omagari, Katsuhisa and Mizuta, Yohei and Murata, Ikuo and Kohno, Shigeru},
 issue = {3-4},
 journal = {Acta medica Nagasakiensia},
 month = {Dec},
 note = {Leukocytapheresis (LCAP) was performed in seven patients with moderate or severe active ulcerative colitis (UC) at the Koga Hospital. LCAP was considered as having been effective in all seven patients (excellent clinical response in five and moderate clinical response in two patients). The excellent or moderate clinical response continued throughout maintenance LCAP in three of seven patients. None of the patients required discontinuation of LCAP, despite the appearance of some side effects, including facial redness, low-grade fever, discomfort, headache and hypotension during the therapy. The results of this study indicate that LCAP may be a safe and effective intensive and maintenance therapy for UC., Acta medica Nagasakiensia. 2002, 47(3-4), p.145-148},
 pages = {145--148},
 title = {Effectiveness and Safety of Leukocytapheresis Therapy for Ulcerative Colitis},
 volume = {47},
 year = {2002}
}